[go: up one dir, main page]

IL158627A0 - Antibacterial agent - Google Patents

Antibacterial agent

Info

Publication number
IL158627A0
IL158627A0 IL15862702A IL15862702A IL158627A0 IL 158627 A0 IL158627 A0 IL 158627A0 IL 15862702 A IL15862702 A IL 15862702A IL 15862702 A IL15862702 A IL 15862702A IL 158627 A0 IL158627 A0 IL 158627A0
Authority
IL
Israel
Prior art keywords
antibacterial agent
antibacterial
agent
Prior art date
Application number
IL15862702A
Original Assignee
Novologix Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10129870A external-priority patent/DE10129870A1/en
Application filed by Novologix Gmbh filed Critical Novologix Gmbh
Publication of IL158627A0 publication Critical patent/IL158627A0/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18Testing for antimicrobial activity of a material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL15862702A 2001-04-30 2002-04-22 Antibacterial agent IL158627A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10121145 2001-04-30
DE10129870A DE10129870A1 (en) 2001-04-30 2001-06-21 Antibacterial
PCT/EP2002/004410 WO2002087554A2 (en) 2001-04-30 2002-04-22 Ef-tu binding agent as antibacterial agent

Publications (1)

Publication Number Publication Date
IL158627A0 true IL158627A0 (en) 2004-05-12

Family

ID=26009202

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15862702A IL158627A0 (en) 2001-04-30 2002-04-22 Antibacterial agent

Country Status (17)

Country Link
EP (1) EP1397157A2 (en)
JP (1) JP2004534016A (en)
CN (1) CN1298739C (en)
AU (1) AU2002302555B2 (en)
BG (1) BG108399A (en)
BR (1) BR0209282A (en)
CA (1) CA2445995A1 (en)
CZ (1) CZ20033271A3 (en)
EE (1) EE200300530A (en)
HU (1) HUP0401586A3 (en)
IL (1) IL158627A0 (en)
MX (1) MXPA03009954A (en)
NZ (1) NZ529662A (en)
PL (1) PL366836A1 (en)
RU (1) RU2003134636A (en)
SK (1) SK14792003A3 (en)
WO (1) WO2002087554A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10229645A1 (en) * 2002-07-02 2004-05-19 Kuchenreuther, Ulrich, Dr. Cell disruption of bacteria
AU2010278860B2 (en) 2009-07-31 2016-05-26 Thar Pharma, Llc Crystallization method and bioavailability
US20160016982A1 (en) 2009-07-31 2016-01-21 Thar Pharmaceuticals, Inc. Crystallization method and bioavailability
US9169279B2 (en) 2009-07-31 2015-10-27 Thar Pharmaceuticals, Inc. Crystallization method and bioavailability
US9340565B2 (en) 2010-11-24 2016-05-17 Thar Pharmaceuticals, Inc. Crystalline forms
CN105218668B (en) * 2015-10-30 2020-03-24 山东农业大学 EF-Tu protein monoclonal antibody MAb of Brucella malta and its preparation method and application
US10195218B2 (en) 2016-05-31 2019-02-05 Grunenthal Gmbh Crystallization method and bioavailability

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0466251A1 (en) * 1990-07-10 1992-01-15 Gist-Brocades N.V. Elfamycin-resistant mutants
ATE343642T1 (en) * 1998-01-23 2006-11-15 Biomerieux Bv EF-TU MRNA AS A MARKER FOR VIABLE BACTERIA
US6451556B1 (en) * 1998-12-21 2002-09-17 Smithkline Beecham Corporation EF-Tu

Also Published As

Publication number Publication date
BG108399A (en) 2004-08-31
BR0209282A (en) 2004-07-27
WO2002087554A3 (en) 2003-01-30
WO2002087554A2 (en) 2002-11-07
HUP0401586A3 (en) 2005-06-28
WO2002087554B1 (en) 2005-01-27
PL366836A1 (en) 2005-02-07
EP1397157A2 (en) 2004-03-17
EE200300530A (en) 2004-04-15
SK14792003A3 (en) 2004-07-07
CN1298739C (en) 2007-02-07
MXPA03009954A (en) 2005-07-25
JP2004534016A (en) 2004-11-11
CN1518455A (en) 2004-08-04
CZ20033271A3 (en) 2004-06-16
HUP0401586A2 (en) 2004-11-29
CA2445995A1 (en) 2002-11-07
AU2002302555B2 (en) 2007-08-23
NZ529662A (en) 2006-08-31
RU2003134636A (en) 2005-04-20

Similar Documents

Publication Publication Date Title
GB0302473D0 (en) Antimicrobial agent
AU2003300965A8 (en) Antibacterial agents
IL160539A0 (en) Anti-influenzal agents
AU2003224345A8 (en) Antibacterial agents
GB0229673D0 (en) Antibacterial agents
IL158627A0 (en) Antibacterial agent
GB0208579D0 (en) Antibacterial agents
GB0106428D0 (en) Antibacterial composition
GB0106987D0 (en) Immunotherapeuitic agent
GB0122162D0 (en) Agent
GB0223532D0 (en) Antibacterial agents
GB0102641D0 (en) Antibacterial agents
GB0123792D0 (en) Antibacterial agents
GB0115197D0 (en) Antibacterial Agents
GB0110705D0 (en) Antibacterial Agents
GB0100949D0 (en) Antibacterial agents
GB0228365D0 (en) Antibacterial agents
GB0204703D0 (en) Antibacterial agent
GB0116864D0 (en) Antimicrobial agents
GB0128234D0 (en) Antimicrobial agents
GB0106487D0 (en) Agent
GB0105442D0 (en) Antibacterial compounds
GB0008844D0 (en) Antimicrobial agent
GB0006119D0 (en) Antimicrobial agent
GB0109914D0 (en) Novel antimicrobial agents